We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
123 hedge funds and large institutions have $344M invested in Lexicon Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.36% less ownership
Funds ownership: 70.57% → 70.21% (-0.36%)
38% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 42
Holders
123
Holding in Top 10
1
Calls
$3.78M
Puts
$450K
Top Buyers
| 1 | +$2.99M | |
| 2 | +$2.48M | |
| 3 | +$786K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$761K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$615K |
Top Sellers
| 1 | -$4.26M | |
| 2 | -$1.85M | |
| 3 | -$1.25M | |
| 4 |
HF
HRT Financial
New York
|
-$502K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$460K |